2018

1. First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study

   Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii183